Aimee Beck

发表

Activated interstitial macrophages are a predominant target of viral takeover and focus of inflammation in COVID-19 initiation in human lung

Aaron J. Wilk, I. Weissman, S. Quake, 2023, bioRxiv.

Combined lineage tracing and scRNA-seq reveals unexpected first heart field predominance of human iPSC differentiation

Sean M. Wu, R. Bak, M. Porteus, 2021, bioRxiv.

Patient-Specific Induced Pluripotent Stem Cells Implicate Intrinsic Impaired Contractility in Hypoplastic Left Heart Syndrome.

E. Ashley, D. Bernstein, Sean M. Wu, 2020, Circulation.

Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2

S. Schaffert, P. Khatri, Rhiju Das, 2022, Nature Medicine.

SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D

Lei S. Qi, C. Blish, A. Rustagi, 2022, bioRxiv.

CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes

Wesley L. McKeithan, B. Pruitt, Guang Li, 2021, Scientific Reports.

Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes.

James B. Hu, P. Doevendans, J. Sluijter, 2020, Cell stem cell.

CRISPRa screening with real world evidence identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2

Aaron J. Wilk, Kathy T. H. Tzeng, Le Cong, 2021, bioRxiv.

The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation

C. Blish, P. Khavari, Yang Zhao, 2021, PLoS pathogens.

Modeling Effects of Immunosuppressive Drugs on Human Hearts Using Induced Pluripotent Stem Cell-Derived Cardiac Organoids and Single-Cell RNA Sequencing.

Kevin C. Wang, I. Y. Chen, A. Rogers, 2022, Circulation.

Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection

J. Shrager, R. Baric, C. Kuo, 2023, Research square.

Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations

Michael Z. Lin, C. Blish, A. Drelich, 2023, bioRxiv.

Combined Lineage Tracing and scRNA-seq Reveals Unexpected First Heart Field 1 Predominance of Human iPSC Differentiation 2 3 4

Sean M. Wu, R. Bak, M. Porteus, 2022 .

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

C. Blish, C. Tseng, S. Einav, 2024, Science Translational Medicine.

Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung

Aaron J. Wilk, M. Krasnow, K. Travaglini, 2024, The Journal of experimental medicine.